| Company/Division name | Unither Pharmaceuticals |
| Parent company | Unither Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 180 |
| Year reshoring announced: | 2024 |
| Capital investment ($): | 106 |
| Country(ies) from which reshored: | France |
| City reshored to: | Rochester |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What non-domestic negative factors made offshoring less attractive? | Green considerations |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Proximity to customers/market, Skilled workforce availability/training |
| Government Incentive dollar amount: | 7 |
